Skip to content
10-Q

Quarterly Report

CymaBay Therapeutics, Inc.

0001193125-23-209009

← back to feed
Filed
Aug 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Jul 31, 2023 98.15M sh
Shares Diluted Q2 2023 · Jun 30, 2023 102.15M sh
Shares Diluted Q2 2023 · Jun 30, 2023 100.07M sh
Shares Diluted Q2 2023 · Jun 30, 2022 87.8M sh
Shares Diluted Q2 2023 · Jun 30, 2022 87.8M sh
Capex Q2 2023 · Jun 30, 2023 $265K
Capex Q2 2023 · Jun 30, 2022 $124K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$19.01M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$47.8M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $35.48M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $20.29M
Stockholders Equity Q2 2023 · Jun 30, 2023 $108.41M
Stockholders Equity Q2 2023 · Mar 31, 2023 $104.19M
Stockholders Equity Q2 2023 · Dec 31, 2022 $36.15M
Stockholders Equity Q2 2023 · Jun 30, 2022 $82.46M
Stockholders Equity Q2 2023 · Mar 31, 2022 $107.38M
Stockholders Equity Q2 2023 · Dec 31, 2021 $132.94M
Current Liabilities Q2 2023 · Jun 30, 2023 $17.89M
Current Liabilities Q2 2023 · Dec 31, 2022 $15.44M
Total Liabilities Q2 2023 · Jun 30, 2023 $118.24M
Total Liabilities Q2 2023 · Dec 31, 2022 $105.7M
Current Assets Q2 2023 · Jun 30, 2023 $224.07M
Current Assets Q2 2023 · Dec 31, 2022 $138.07M
Total Assets Q2 2023 · Jun 30, 2023 $226.65M
Total Assets Q2 2023 · Dec 31, 2022 $141.85M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.01
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.30
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.31
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.62
Eps Basic Q2 2023 · Jun 30, 2023 −$0.01
Eps Basic Q2 2023 · Jun 30, 2023 −$0.30
Eps Basic Q2 2023 · Jun 30, 2022 −$0.31
Eps Basic Q2 2023 · Jun 30, 2022 −$0.62
Sga Expense Q2 2023 · Jun 30, 2023 $11.58M
Sga Expense Q2 2023 · Jun 30, 2023 $19.9M
Sga Expense Q2 2023 · Jun 30, 2022 $5.88M
Sga Expense Q2 2023 · Jun 30, 2022 $11.97M
Rd Expense Q2 2023 · Jun 30, 2023 $19.54M
Rd Expense Q2 2023 · Jun 30, 2023 $38.09M
Rd Expense Q2 2023 · Jun 30, 2022 $17.89M
Rd Expense Q2 2023 · Jun 30, 2022 $36.31M
Net Income Q2 2023 · Jun 30, 2023 −$808K
Net Income Q2 2023 · Jun 30, 2023 −$29.59M
Net Income Q2 2023 · Mar 31, 2023 −$28.78M
Net Income Q2 2023 · Jun 30, 2022 −$27.09M
Net Income Q2 2023 · Jun 30, 2022 −$54.86M
Net Income Q2 2023 · Mar 31, 2022 −$27.77M
Operating Income Q2 2023 · Jun 30, 2023 −$99K
Operating Income Q2 2023 · Jun 30, 2023 −$26.97M
Operating Income Q2 2023 · Jun 30, 2022 −$23.77M
Operating Income Q2 2023 · Jun 30, 2022 −$48.27M
Stock Issued Q2 2023 · Jan 23, 2023 11.82M sh